Concourse Financial Group Securities, Inc. Tg Therapeutics, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share
Q3 2024 Oct 10, 2024	BUY	$17.21 - $25.28 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$13.32 - $19.19 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$13.02 - $21.3 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$6.68 - $18.81 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$8.36 - $26.5 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$8.36 - $26.5 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$15.48 - $35.0 $0 - $0
Q1 2023 May 15, 2023	BUY	$10.23 - $19.34 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$5.01 - $11.83 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$4.57 - $8.4 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$3.74 - $10.66 $0 - $0
Q1 2022 May 09, 2022	BUY	$7.81 - $20.45 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$15.2 - $35.51 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$21.78 - $40.45 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$32.5 - $48.96 $0 - $0
Q1 2021 May 13, 2021	BUY	$41.61 - $54.3 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$25.27 - $54.9 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$18.49 - $27.24 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$8.9 - $21.84 $0 - $0
Q1 2020 May 13, 2020	BUY	$7.14 - $15.99 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$5.1 - $11.2 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$5.38 - $8.99 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$6.27 - $8.65 $0 - $0
Q1 2019 May 15, 2019	BUY	$4.02 - $8.04 $0 - $0
Q4 2018 Feb 14, 2019	BUY	$3.44 - $5.76 $0 - $0
Q3 2018 Nov 13, 2018	BUY	$5.15 - $14.0 $0 - $0

Others Institutions Holding TGTX

# of Institutions

312

Shares Held

93M

Call Options Held

1.9M

Put Options Held

1.45M

Vanguard Group Inc Valley Forge, PA

13.7M
Shares

$372 Million
0.0% of portfolio
Black Rock Inc. New York, NY

11.4M
Shares

$309 Million
0.0% of portfolio
State Street Corp Boston, MA

6.7M
Shares

$182 Million
0.01% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

3.65M
Shares

$99 Million
6.57% of portfolio
Pictet Asset Management Holding Sa Carouge, V8

3.24M
Shares

$88.1 Million
0.07% of portfolio

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $3.95B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account